| Manager | Title | Age | Since |
|---|---|---|---|
Anita Johansen
CEO | Chief Executive Officer | 54 | 2022-12-07 |
Johan Flink
DFI | Director of Finance/CFO | 49 | 2025-07-31 |
James Henson
COO | Chief Operating Officer | 39 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jörn Andreas
BRD | Director/Board Member | 45 | 2013-12-31 |
| Chairman | 62 | 2015-03-31 | |
| Director/Board Member | 64 | 2017-05-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/3/25 | Buy | Company | 142,586 | 1.2514% | ||
| 1/21/25 | Buy | Company | 2,840,101 | 24.9260% | ||
| 11/28/24 | Buy | Company | 33,086 | 0.2904% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.29% | - | - | 33.68M | ||
| +1.04% | +2.34% | +54.91% | +111.75% | 1,038B | ||
| -0.19% | +1.18% | +52.94% | +66.69% | 649B | ||
| +0.20% | +1.04% | +18.88% | +72.38% | 467B | ||
| -0.70% | +0.17% | +33.23% | +44.83% | 355B | ||
| +0.13% | +2.11% | +18.25% | +26.43% | 269B | ||
| +0.41% | +4.01% | +9.58% | +14.09% | 260B | ||
| +1.95% | +3.06% | +37.75% | +45.93% | 213B | ||
| -0.28% | -6.31% | -32.54% | -59.70% | 176B | ||
| +0.30% | +2.83% | +31.97% | +100.03% | 187B | ||
| Average | +0.38% | +1.04% | +25.00% | +46.94% | 401.68B | |
| Weighted average by Cap. | +0.61% | +1.47% | +35.32% | +65.77% |
Employees
-
Sector
Pharmaceuticals
















